Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Share News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: -1.00 (-2.44%)
Spread: 2.00 (5.128%)
Open: 41.00
High: 41.00
Low: 40.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Frontier IP Group Interim Profit More Than Doubles On Revaluation

Wed, 27th Mar 2019 10:57

LONDON (Alliance News) - Frontier IP Group PLC on Wednesday said its interim pretax profit more than doubled compared to the prior year due to gains on the revaluation of its investments.

Frontier IP specialises in commercialising university intellectual property.

For the six months to the end of 2018, the company posted a rise in pretax profit to GBP1.2 million from GBP524,000, due to a gain on portfolio revaluation.

Total revenue rose 83% to GBP2.2 million from GBP1.2 million, with the increase reflecting a higher gain on the revaluation of investments of GBP2.0 million versus GBP1.1 million a year prior.

Meanwhile, in the six-month period the fair value of the company's portfolio increased 27% to GBP11.5 million at the end of December from GBP9.1 million at the end of June.

Net assets per share rose to 38.8 pence from 32.0p a year ago, and from 33.2p at June 30 last year.

"Our business model is based on proving the commercial value of intellectual property by working closely with universities, academics and industry. Only when we are confident the technology works, can be scaled up, and meets a market need or demand, will we ask investors to make significant commitments to the portfolio companies," Chief Executive Officer Neil Crabb said.

"We are mindful of the risks in the group. The nature of the early and development stage companies in our portfolio means their rate of progress or eventual success cannot always be assured. However, these are strong results."

"The momentum has gathered pace into the second half of the year. That's why, based on trading for the year to date and what we see coming down the line, we anticipate that the outcome for the full financial year, ending June 2019, will be ahead of management expectations."

Furthermore, the company said that Matthew White, director of commercialisation since September, has been appointed to its board. He will continue operating in his role.

Frontier IP shares were 2.5% higher at 83.00p each on Wednesday morning.

More News
26 May 2020 14:46

Frontier IP Investee Exscientia Raises USD60 Million To Fund Expansion

Frontier IP Investee Exscientia Raises USD60 Million To Fund Expansion

Read more
26 May 2020 11:43

Frontier IP investment Exscientia raises $60m in series C round

(Sharecast News) - Intellectual property company Frontier IP said on Tuesday that its portfolio company, AI-driven drug discovery firm Exscientia, has raised $60m (£49.1m) through a series C financing round.

Read more
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more
9 Apr 2020 15:24

Frontier IP Group Investee Alusid Launches Luxury Table Brand

Frontier IP Group Investee Alusid Launches Luxury Table Brand

Read more
1 Apr 2020 17:56

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

Read more
13 Mar 2020 14:23

Frontier IP shares rise on progress at The Vaccine Group

(Sharecast News) - University intellectual property commercialisation company Frontier IP noted an announcement below from its portfolio company The Vaccine Group (TVG) on Friday, about the material progress it was making with its novel vaccine technology, and the start of work on a Covid-19 coronavirus vaccine for use in animals.

Read more
13 Mar 2020 12:59

Frontier IP's Vaccine Group Working On Covid-19 Vaccine For Animals

Frontier IP's Vaccine Group Working On Covid-19 Vaccine For Animals

Read more
17 Feb 2020 11:47

Frontier IP Investee Secures EU Funding For Microscope Development

Frontier IP Investee Secures EU Funding For Microscope Development

Read more
12 Feb 2020 11:39

Frontier IP Ups Stake In AI Firm Celerum Amid "Industry Interest"

Frontier IP Ups Stake In AI Firm Celerum Amid "Industry Interest"

Read more
31 Jan 2020 17:32

Frontier IP Notes First Trials Of Exscientia's OCD Drug Candidate

Frontier IP Notes First Trials Of Exscientia's OCD Drug Candidate

Read more
20 Jan 2020 12:23

Frontier IP Investee Vaccine Group Secures GBP680,000 In Funding

Frontier IP Investee Vaccine Group Secures GBP680,000 In Funding

Read more
14 Jan 2020 14:58

Frontier IP portfolio firm Fieldwork raises ?0.3m for fruit picking robot

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Tuesday that its portfolio company, Fieldwork Robotics, has raised £0.298m through an initial equity funding round.

Read more
14 Jan 2020 12:36

Frontier IP Investee Fieldwork Robotics Raises Almost GBP300,000

Frontier IP Investee Fieldwork Robotics Raises Almost GBP300,000

Read more
10 Jan 2020 15:25

Frontier IP upbeat as portfolio company partners with Bayer

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Friday that its portfolio company Exscientia, which focuses on artificial intelligence (AI) driven drug discovery, has entered into a collaboration with Bayer focused on cardiovascular disease and oncology.

Read more
6 Nov 2019 14:38

UPDATE: Frontier IP Raises GBP3.8 Million Via Oversubscribed Placing

UPDATE: Frontier IP Raises GBP3.8 Million Via Oversubscribed Placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.